Development of a UK liver transplantation selection and allocation scheme

Area of Science:

• Organ transplantation
• Medical ethics
• Public health policy

Background:

• Equitable organ allocation for liver transplantation is a critical research area.
• UK transplant schemes evaluate success based on outcomes from national list registration, including waiting time.
• Established criteria exist for chronic liver disease, hepatocellular carcinoma, and variant syndromes.

Purpose of the Study:

• To compare different organ allocation models: by need, utility, and transplant benefit.
• To assess these models against the current unit-based allocation system.
• To determine the optimal strategy for liver transplant allocation in the UK.

Main Methods:

• Simulation modeling was used to compare allocation strategies.
• The study evaluated outcomes including waiting list mortality and population life years gained.
• The transplant benefit model (net life years gained) was a key focus.

Main Results:

• The transplant benefit model demonstrated a reduction in waiting list deaths.
• This model was shown to maximize overall population life years.
• The UK adopted a national list prioritizing transplant benefit in March 2018.

Conclusions:

• Prioritizing liver transplant allocation by transplant benefit (net life years gained) is an effective strategy.
• This approach optimizes resource allocation and improves patient outcomes.
• The UK's shift to a national list based on transplant benefit reflects a move towards maximizing societal health gains.